Literature DB >> 14463177

Study of phendimetrazine bitartrate as an appetite suppressant in relation to dosage, weight loss and side effects.

W H LE RICHE, G VAN BELLE.   

Abstract

Entities:  

Keywords:  APPETITE/pharmacology; OBESITY/therapy; SYMPATHOMIMETICS/therapy

Mesh：

Substances：

Year:  1962        PMID： 14463177      PMCID： PMC1849287     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Evaluation of phendimetrazine bitartrate as an appetite suppressant.

Authors:  L J CASS
Journal:  Can Med Assoc J       Date:  1961-05-20       Impact factor: 8.262

2.  The measurment of success in weight reduction. An analysis of methods and new index.

Authors:  A R FEINSTEIN
Journal:  J Chronic Dis       Date:  1959-11
  2 in total
  3 in total

Review 1.  CNS-targeting pharmacological interventions for the metabolic syndrome.

Authors:  Kerstin Stemmer; Timo D Müller; Richard D DiMarchi; Paul T Pfluger; Matthias H Tschöp
Journal:  J Clin Invest       Date:  2019-08-05       Impact factor: 14.808

2.  Management of diabetes across the course of disease: minimizing obesity-associated complications.

Authors:  Caroline M Apovian
Journal:  Diabetes Metab Syndr Obes       Date:  2011-10-12       Impact factor: 3.168

Review 3.  Weight management in obesity - past and present.

Authors:  D Haslam
Journal:  Int J Clin Pract       Date:  2016-01-26       Impact factor: 2.503
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.